MENU
+Compare
CELC
Stock ticker: NASDAQ
AS OF
Jul 16, 04:59 PM (EDT)
Price
$13.85
Change
+$0.07 (+0.51%)
Capitalization
521.8M

CELC Celcuity Forecast, Technical & Fundamental Analysis

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology... Show more

CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CELC with price predictions
Jul 15, 2025

Momentum Indicator for CELC turns positive, indicating new upward trend

CELC saw its Momentum Indicator move above the 0 level on June 30, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CELC just turned positive on June 30, 2025. Looking at past instances where CELC's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CELC advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 179 cases where CELC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CELC moved out of overbought territory on June 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where CELC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CELC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CELC broke above its upper Bollinger Band on July 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CELC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.020) is normal, around the industry mean (17.548). P/E Ratio (0.000) is within average values for comparable stocks, (58.754). CELC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.452). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (269.838).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CELC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CELC is expected to report earnings to rise 2.71% to -88 cents per share on August 07

Celcuity CELC Stock Earnings Reports
Q2'25
Est.
$-0.88
Q1'25
Missed
by $0.14
Q4'24
Missed
by $0.04
Q3'24
Est.
$-0.65
Q2'24
Beat
by $0.10
The last earnings report on May 14 showed earnings per share of -86 cents, missing the estimate of -72 cents. With 56.11K shares outstanding, the current market capitalization sits at 521.80M.
A.I. Advisor
published General Information

General Information

a biotechnology company develops novel diagnostic tests

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
16305 36th Avenue North
Phone
+1 763 392-0767
Employees
55
Web
https://www.celcuity.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAOIX38.26N/A
N/A
Fidelity Advisor Overseas I
FEYCX28.01N/A
N/A
Fidelity Advisor Asset Manager 85% C
PSSPX26.91N/A
N/A
Principal SmallCap S&P 600 Index R5
LAVGX16.04N/A
N/A
Lord Abbett International Growth R6
TCFSCV10.50-0.23
-2.14%
Thrivent Core Small Cap Value

CELC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with IMNM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+0.22%
IMNM - CELC
45%
Loosely correlated
-1.29%
ABOS - CELC
45%
Loosely correlated
-12.08%
COGT - CELC
44%
Loosely correlated
+3.70%
RXRX - CELC
44%
Loosely correlated
-1.14%
RAPP - CELC
44%
Loosely correlated
-1.71%
More